Prevalence and Factors Increasing the Risk of Sarcopenia among Patients with Kidney Disease Followed up at the Douala General Hospital, Cameroon — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Prevalence and Factors Increasing the Risk of Sarcopenia among Patients with Kidney Disease Followed up at the Douala General Hospital, Cameroon
Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon
,
Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon
,
Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon
,
General Douala Hospital, Douala, Cameroon
,
Yaounde University Teaching Hospital, Yaoundé, Cameroon
,
Yaoundé Central Hospital, Yaoundé, Cameroon
1 Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon
2 Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon
3 Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon
4 General Douala Hospital, Douala, Cameroon
5 Yaounde University Teaching Hospital, Yaoundé, Cameroon
Background: Sarcopenia is an important prognostic factor for patients with kidney disease. In a context marked by the poor prognosis of these patients, we aimed to explore the factors that could potentially worsen outcomes. The objective of our study was to determine the prevalence and identify factors increasing the risk of sarcopenia among patients with kidney disease followed up at Douala General Hospital (DGH). Methods: We conducted a cross-sectional study in the nephrology department of DGH over a 6-month period, including 302 patients with kidney disease. Sociodemographic and clinical data were collected from each participant using a structured questionnaire and their medical records. The diagnosis of sarcopenia was made according to the EWGSOP2 recommendations. Univariate and multivariate logistic regressions were performed to identify factors associated with an increased risk of sarcopenia. Results: The mean age of patients was 61 ± 13 years, with most being in the 50 - 64-year age group (n = 127, 42%) and male (n = 159, 53%). The prevalence of sarcopenia was 28.8%. Probable sarcopenia was observed in 50 patients (16.6%), confirmed sarcopenia in 9.3% and severe sarcopenia in 3%. The risk of sarcopenia increased among patients older than 65 years (aOR = 19.4, 95% CI: 2.25 - 445; p = 0.017), those consuming alcohol (aOR = 7.88, 95% CI: 2.82 - 25.1; p < 0.001), with type II diabetes (aOR = 83.1, 95% CI: 22.9 - 411; p < 0.001), with advanced CKD stages—G3 (aOR = 13.9, 95% CI: 2.73 - 100; p = 0.004), G4 (aOR = 149, 95% CI: 22.2 - 1571; p < 0.001) and G5 (aOR = 736, 95% CI: 93.9 - 9414; p < 0.001)—, and those with elevated serum IL-6 concentrations (aOR = 54.6, 95% CI: 16.3 - 238; p < 0.001). Conclusion: The prevalence of sarcopenia was substantial in our sample, and its risk was increased by older age, type II diabetes, alcohol consumption, advanced CKD stage, and elevated serum IL-6 levels.
KeywordsKidney DiseaseSarcopeniaPrevalenceRiskDouala General Hospital
Cruz-Jentoft, A.J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., et al . (2019) Sarcopenia: Revised European Consensus on Definition and Diagnosis. Age and Ageing , 48, 601-601. https://doi.org/10.1093/ageing/afz046
Cruz-Jentoft, A.J., Baeyens, J.P., Bauer, J.M., Boirie, Y., Cederholm, T., Landi, F., et al. (2010) Sarcopenia: European Consensus on Definition and Diagnosis. Age and Ageing , 39, 412-423. https://doi.org/10.1093/ageing/afq034
Sayer, A.A. and Cruz-Jentoft, A. (2022) Sarcopenia Definition, Diagnosis and Treatment: Consensus Is Growing. Age and Ageing , 51, afac220. https://doi.org/10.1093/ageing/afac220
Workeneh, B.T. and Mitch, W.E. (2010) Review of Muscle Wasting Associated with Chronic Kidney Disease. The American Journal of Clinical Nutrition , 91, 1128S-1132S. https://doi.org/10.3945/ajcn.2010.28608b
Liao, M., Sung, C., Hung, K., Wu, C., Lo, L. and Lu, K. (2012) Insulin Resistance in Patients with Chronic Kidney Disease. Journal of Biomedicine and Biotechnology , 2012, Article ID: 691369. https://doi.org/10.1155/2012/691369
Carrero, J.J., Stenvinkel, P., Cuppari, L., Ikizler, T.A., Kalantar-Zadeh, K., Kaysen, G., et al . (2013) Etiology of the Protein-Energy Wasting Syndrome in Chronic Kidney Disease: A Consensus Statement from the International Society of Renal Nutrition and Metabolism (ISRNM). Journal of Renal Nutrition , 23, 77-90. https://doi.org/10.1053/j.jrn.2013.01.001
Kadatane, S.P., Satariano, M., Massey, M., Mongan, K. and Raina, R. (2023) The Role of Inflammation in CKD. Cells , 12, Article 1581. https://doi.org/10.3390/cells12121581
Duarte, M.P., Almeida, L.S., Neri, S.G.R., Oliveira, J.S., Wilkinson, T.J., Ribeiro, H.S., et al . (2024) Prevalence of Sarcopenia in Patients with Chronic Kidney Disease: A Global Systematic Review and Meta-Analysis. Jo urnal of Cachexia , Sarcopenia and Muscle , 15, 501-512. https://doi.org/10.1002/jcsm.13425
Wathanavasin, W., Banjongjit, A., Avihingsanon, Y., Praditpornsilpa, K., Tungsanga, K., Eiam-Ong, S., et al . (2022) Prevalence of Sarcopenia and Its Impact on Cardiovascular Events and Mortality among Dialysis Patients: A Systematic Review and Meta-Analysis. Nutrients , 14, Article 4077. https://doi.org/10.3390/nu14194077
Shu, X., Lin, T., Wang, H., Zhao, Y., Jiang, T., Peng, X., et al . (2022) Diagnosis, Prevalence, and Mortality of Sarcopenia in Dialysis Patients: A Systematic Review and Meta-Analysis. Journal of Cachexia , Sarcopenia and Muscle , 13, 145-158. https://doi.org/10.1002/jcsm.12890
Wilkinson, T.J., Miksza, J., Yates, T., Lightfoot, C.J., Baker, L.A., Watson, E.L., et al . (2021) Association of Sarcopenia with Mortality and End-Stage Renal Disease in Those with Chronic Kidney Disease: A UK Biobank Study. Journal of Cachexia , Sarcopenia and Muscle , 12, 586-598. https://doi.org/10.1002/jcsm.12705
Santana Gomes, T., Espirito Santo Silva, D.D., Xavier Junior, G.F., de Farias Costa, P.R., Gusmão Sena, M.H.L. and Barreto Medeiros, J.M. (2022) Sarcopenia and Mortality in Patients with Chronic Non-Dialytic Renal Disease: Systematic Review and Meta-Analysis. Journal of Renal Nutrition , 32, 135-143. https://doi.org/10.1053/j.jrn.2021.02.004
Bonanni, A., Mannucci, I., Verzola, D., Sofia, A., Saffioti, S., Gianetta, E., et al . (2011) Protein-Energy Wasting and Mortality in Chronic Kidney Disease. International Journal of Environmental Research and Public Health , 8, 1631-1654. https://doi.org/10.3390/ijerph8051631
Halle, M.P., Ashuntantang, G., Kaze, F.F., Takongue, C. and Kengne, A. (2016) Fatal Outcomes among Patients on Maintenance Haemodialysis in Sub-Saharan Africa: A 10-Year Audit from the Douala General Hospital in Cameroon. BMC Nephrology , 17, Article No. 165. https://doi.org/10.1186/s12882-016-0377-5
Aseneh, J.B., Kemah, B.A., Mabouna, S., Njang, M.E., Ekane, D.S.M. and Agbor, V.N. (2020) Chronic Kidney Disease in Cameroon: A Scoping Review. BMC Nephrology , 21, Article No. 409. https://doi.org/10.1186/s12882-020-02072-5
Malmstrom, T.K., Miller, D.K., Simonsick, E.M., Ferrucci, L. and Morley, J.E. (2015) SARC-F: A Symptom Score to Predict Persons with Sarcopenia at Risk for Poor Functional Outcomes. Journal of Cachexia , Sarcopenia and Muscle , 7, 28-36. https://doi.org/10.1002/jcsm.12048
Bahat, G., Yilmaz, O., Kiliç, C., Oren, M.M. and Karan, M.A. (2018) Performance of SARC-F in Regard to Sarcopenia Definitions, Muscle Mass and Functional Measures. The Journal of nutrition , health and aging , 22, 898-903. https://doi.org/10.1007/s12603-018-1067-8
Pourhoseingholi, M.A., Vahedi, M. and Rahimzadeh, M. (2013) Sample Size Calculation in Medical Studies. Gastroenterol Hepatol Bed Bench , 6, 14-17.
Roberts, H.C., Denison, H.J., Martin, H.J., Patel, H.P., Syddall, H., Cooper, C., et al . (2011) A Review of the Measurement of Grip Strength in Clinical and Epidemiological Studies: Towards a Standardised Approach. Age and Ageing , 40, 423-429. https://doi.org/10.1093/ageing/afr051
Janssen, I., Heymsfield, S.B., Wang, Z. and Ross, R. (2000) Skeletal Muscle Mass and Distribution in 468 Men and Women Aged 18-88 Yr. Journal of Applied Physiology , 89, 81-88. https://doi.org/10.1152/jappl.2000.89.1.81
Morley, J.E., Abbatecola, A.M., Argilés, J.M., Baracos, V., Bauer, J., Bhasin, S., et al . (2011) Sarcopenia with Limited Mobility: An International Consensus. Journal of the American Medical Directors Association , 12, 403-409. https://doi.org/10.1016/j.jamda.2011.04.014
Moorthi, R.N. and Avin, K.G. (2017) Clinical Relevance of Sarcopenia in Chronic Kidney Disease. Current Opinion in Nephrology and Hypertension , 26, 219-228. https://doi.org/10.1097/mnh.0000000000000318
Gulcicek, S. and Seyahi, N. (2023) Factors Associated with Sarcopenia in Patients with Chronic Kidney Disease: A Cross-Sectional Single-Center Study. Medical Science Monitor , 29, e939457. https://doi.org/10.12659/msm.939457
Huang, Y., Liu, S., Muo, C., Lai, C. and Chang, C. (2024) Male Sex and Ageing Are Independent Risk Factors for Sarcopenia Stage in Patients with Chronic Kidney Disease Not Yet on Dialysis. Journal of Cachexia , Sarcopenia and Muscle , 15, 2684-2692. https://doi.org/10.1002/jcsm.13612
Hirai, K., Ookawara, S. and Morishita, Y. (2016) Sarcopenia and Physical Inactivity in Patients with Chronic Kidney Disease. Nephro - Urology Monthly , 8, e37443. https://doi.org/10.5812/numonthly.37443
Chatzipetrou, V., Bégin, M., Hars, M. and Trombetti, A. (2021) Sarcopenia in Chronic Kidney Disease: A Scoping Review of Prevalence, Risk Factors, Association with Outcomes, and Treatment. Calcified Tissue International , 110, 1-31. https://doi.org/10.1007/s00223-021-00898-1
Veronese, N., Pizzol, D., Demurtas, J., Soysal, P., Smith, L., Sieber, C., et al . (2019) Association between Sarcopenia and Diabetes: A Systematic Review and Meta-Analysis of Observational Studies. European Geriatric Medicine , 10, 685-696. https://doi.org/10.1007/s41999-019-00216-x
Quan, Y., Wang, C., Wang, L. and Li, G. (2023) Geriatric Sarcopenia Is Associated with Hypertension: A Systematic Review and Meta-Analysis. The Journal of Clinical Hypertension , 25, 808-816. https://doi.org/10.1111/jch.14714
Bu, Y., Wang, C., Zhao, C., Lu, X. and Gao, W. (2024) The Association of Alcohol Consumption with the Risk of Sarcopenia: A Dose-Response Meta-Analysis. The American Journal of Drug and Alcohol Abuse , 50, 305-320. https://doi.org/10.1080/00952990.2023.2300049
Steffl, M., Bohannon, R.W., Petr, M., Kohlikova, E. and Holmerova, I. (2015) Relation between Cigarette Smoking and Sarcopenia: Meta-Analysis. Physiological Research , 64, 419-426. https://doi.org/10.33549/physiolres.932802
Hong, S. and Bae, Y. (2022) Association between Alcohol Consumption and the Risk of Sarcopenia: A Systematic Review and Meta-Analysis. Nutrients , 14, Article 3266. https://doi.org/10.3390/nu14163266
Pereira, R.A., Cordeiro, A.C., Avesani, C.M., Carrero, J.J., Lindholm, B., Amparo, F.C., et al . (2015) Sarcopenia in Chronic Kidney Disease on Conservative Therapy: Prevalence and Association with Mortality. Nephrology Dialysis Transplantation , 30, 1718-1725. https://doi.org/10.1093/ndt/gfv133
Swan, L., Warters, A. and O’Sullivan, M. (2021) Socioeconomic Inequality and Risk of Sarcopenia in Community-Dwelling Older Adults. Clinical Interventions in Aging , 16, 1119-1129. https://doi.org/10.2147/cia.s310774
Yang, J., Huang, J., Yang, X., Li, S., Wu, X. and Ma, X. (2023) The Association of Living Alone and Social Isolation with Sarcopenia: A Systematic Review and Meta-Analysis. Ageing Research Reviews , 91, Article ID: 102043. https://doi.org/10.1016/j.arr.2023.102043
Sabatino, A., Cuppari, L., Stenvinkel, P., Lindholm, B. and Avesani, C.M. (2020) Sarcopenia in Chronic Kidney Disease: What Have We Learned So Far? Journal of Nephrology , 34, 1347-1372. https://doi.org/10.1007/s40620-020-00840-y
Otobe, Y., Rhee, C.M., Nguyen, M., Kalantar-Zadeh, K. and Kopple, J.D. (2021) Current Status of the Assessment of Sarcopenia, Frailty, Physical Performance and Functional Status in Chronic Kidney Disease Patients. Current Opinion in Nephrology & Hypertension , 31, 109-128. https://doi.org/10.1097/mnh.0000000000000763
Lamarca, F., Carrero, J.J., Rodrigues, J.C.D., Bigogno, F.G., Fetter, R.L. and Avesani, C.M. (2014) Prevalence of Sarcopenia in Elderly Maintenance Hemodialysis Patients: The Impact of Different Diagnostic Criteria. The Journal of nutrition , health and aging , 18, 710-717. https://doi.org/10.1007/s12603-014-0505-5
Abdala, R., Elena del Valle, E., Negri, A.L., Bridoux, P., Paganti, L.G., Bravo, M., et al . (2021) Sarcopenia in Hemodialysis Patients from Buenos Aires, Argentina. Osteoporosis and Sarcopenia , 7, 75-80. https://doi.org/10.1016/j.afos.2021.04.001
de Amorim, G.J., Calado, C.K.M., Souza de Oliveira, B.C., Araujo, R.P.O., Filgueira, T.O., de Sousa Fernandes, M.S., et al . (2022) Sarcopenia in Non-Dialysis Chronic Kidney Disease Patients: Prevalence and Associated Factors. Frontiers in Medicine , 9, Article 854410. https://doi.org/10.3389/fmed.2022.854410
Kaze, A.D., Ilori, T., Jaar, B.G. and Echouffo-Tcheugui, J.B. (2018) Burden of Chronic Kidney Disease on the African Continent: A Systematic Review and Meta-Analysis. BMC Nephrology , 19, Article No. 125. https://doi.org/10.1186/s12882-018-0930-5
Isoyama, N., Qureshi, A.R., Avesani, C.M., Lindholm, B., Bàràny, P., Heimbürger, O., et al . (2014) Comparative Associations of Muscle Mass and Muscle Strength with Mortality in Dialysis Patients. Clinical Journal of the American Society of Nephrology , 9, 1720-1728. https://doi.org/10.2215/cjn.10261013
McCormick, R. and Vasilaki, A. (2018) Age-Related Changes in Skeletal Muscle: Changes to Life-Style as a Therapy. Biogerontology , 19, 519-536. https://doi.org/10.1007/s10522-018-9775-3
Morton, R.W., Traylor, D.A., Weijs, P.J.M. and Phillips, S.M. (2018) Defining Anabolic Resistance: Implications for Delivery of Clinical Care Nutrition. Current Opinion in Critical Care , 24, 124-130. https://doi.org/10.1097/mcc.0000000000000488
Ai, Y., Xu, R. and Liu, L. (2021) The Prevalence and Risk Factors of Sarcopenia in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Diabetology & Metabolic Syndrome , 13, Article No. 93. https://doi.org/10.1186/s13098-021-00707-7
Skinner, J., Shepstone, L., Hickson, M. and Welch, A.A. (2023) Alcohol Consumption and Measures of Sarcopenic Muscle Risk: Cross-Sectional and Prospective Associations within the UK Biobank Study. Calcified Tissue International , 113, 143-156. https://doi.org/10.1007/s00223-023-01081-4
Choi, Y.S., An, J.N., Kim, J., Kim, S.G. and Song, Y.R. (2021) Late Stage 3 CKD Is an Independent Risk Factor for Sarcopenia, but Not Proteinuria. Journal of the American Society of Nephrology , 32, 540-540. https://doi.org/10.1681/asn.20213210s1540c
Kim, D.W. and Song, S.H. (2023) Sarcopenia in Chronic Kidney Disease: From Bench to Bedside. The Korean Journal of Internal Medicine , 38, 303-321. https://doi.org/10.3904/kjim.2022.338
Wang, K., Liu, Q., Tang, M., Qi, G., Qiu, C., Huang, Y., et al . (2023) Chronic Kidney Disease-Induced Muscle Atrophy: Molecular Mechanisms and Promising Therapies. Biochemical Pharmacology , 208, Article ID: 115407. https://doi.org/10.1016/j.bcp.2022.115407
Schaap, L.A., Pluijm, S.M.F., Deeg, D.J.H. and Visser, M. (2006) Inflammatory Markers and Loss of Muscle Mass (Sarcopenia) and Strength. The American Journal of Medicine , 119, 526.e9-526.e17. https://doi.org/10.1016/j.amjmed.2005.10.049